High Dose BAYA1040_Nifedipine: a Long Term Combination Study
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This is a clinical study evaluating the safety and efficacy of long term administration of
oral BAYA1040_Nifedipine 80 mg/day (40 mg twice daily) with other antihypertensives in
patients with essential hypertension who are not at target blood pressure by the combination
of BAYA1040_Nifedipine 40 mg once daily and other antihypertensives.